Home › Kanser sa Prostate › Alabama
Pag-aaral pangklinika para sa Kanser sa Prostate sa Alabama
13 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Alabama.
Mga Lungsod sa Alabama
Opisyal na teksto ng pag-aaral (English)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- University of Alabama at Birmingham, Birmingham
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Nob 12, 2026 · NCT06511141Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Alabama at Birmingham Cancer Center, Birmingham
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Alabama at Birmingham Hospital, Birmingham
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 29, 2026 · NCT05519449Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Lewis and Faye Manderson Cancer Center, Tuscaloosa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Dothan
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 19, 2026 · NCT07611110Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Urology Centers Of Alabama Pc, Homewood
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 15, 2026 · NCT06855277This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT07028853DESTINY-PANTUMOUR04
- Research Site, Birmingham
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Alabama Birmingham Hospital, Birmingham
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT06056830A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Clearview Cancer Institute, Huntsville
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 3, 2026 · NCT07005154International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Alabama- Tuscaloosa, Tuscaloosa
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Kalalakihan · Na-update May 22, 2026 · NCT03151629SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.